Apart from CD44, HA also interacts with CD44‐like receptors such as HA‐mediated motility receptor (RHAMM) and lymphatic vessel endothelial receptor‐1 (LYVE‐1), which are also overexpressed in tumor cells (Misra et al., 2015). Here, CD44 is linked to neoplasm.